This study is in progress, not accepting new patients
A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness
Summary
- Eligibility
- for people ages 18-65 (full criteria)
- Location
- at San Diego, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- ViaCyte
- ID
- NCT03163511
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- About 49 people participating
- Last Updated